Phase 1 Advanced Malignant Solid Tumor Clinical Trials
18 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–18 of 18 trials
Recruiting
Phase 1Phase 2
A Study of MHB042C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192107
Recruiting
Phase 1Phase 2
A Study of MHB009C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07326488
Recruiting
Phase 1Phase 2
A Study of MHB048C in Patients With Advanced Solid Tumors
Advanced Malignant Solid TumormCRPC (Metastatic Castration-resistant Prostate Cancer)
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192120
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2062 in Patients With Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT07262164
Recruiting
Phase 1
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Solid Tumor CancerAdvanced Malignant Solid Tumor
Pilatus Biosciences Inc36 enrolled2 locationsNCT07337525
Recruiting
Phase 1Phase 2
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
Advanced Malignant Solid Tumor
Repertoire Immune Medicines150 enrolled1 locationNCT07293754
Recruiting
Phase 1
A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function
Advanced Malignant Solid TumorHepatic Impairment
Epizyme, Inc.24 enrolled18 locationsNCT04241835
Recruiting
Phase 1Phase 2
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd116 enrolled1 locationNCT07126665
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Mesothelin-Expressing TumorsEpithelial Ovarian CancerLung Adenocarcinoma Metastatic+7 more
Context Therapeutics Inc.70 enrolled8 locationsNCT06756035
Recruiting
Phase 1Phase 2
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Advanced Malignant Solid Tumor
Sinocelltech Ltd.110 enrolled1 locationNCT07050641
Recruiting
Phase 1
A Study of MHB118C Injection in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07045454
Recruiting
Phase 1
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University12 enrolled1 locationNCT06912152
Recruiting
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients with Solid Tumors
Advanced Malignant Solid Tumor
Shanghai Virogin Biotech Co., Ltd.30 enrolled1 locationNCT05477849
Recruiting
Phase 1
A Study of MT027 in Patients with Pleural Malignant Tumors
Malignant Pleural EffusionAdvanced Malignant Solid TumorPleural Metastases+3 more
Suzhou Maximum Bio-tech Co., Ltd.18 enrolled1 locationNCT06726564
Recruiting
Phase 1
To Evaluate the Phase I Clinical Study of JSKN016 in Chinese Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Jiangsu Alphamab Biopharmaceuticals Co., Ltd140 enrolled2 locationsNCT06592417
Recruiting
Phase 1
Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
CDH17-positive Advanced Malignant Solid Tumors
Shanghai Pudong Hospital17 enrolled1 locationNCT06501183
Recruiting
Phase 1Phase 2
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
CAS Lamvac Biotech Co., Ltd.60 enrolled1 locationNCT04165590
Terminated
Phase 1
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.
Advanced malignant solid tumors
Virogin Biotech Australia Pty. Ltd.36 enrolled3 locationsACTRN12620000244909